InspireMD, Inc. (NYSE:NSPR) has made a 30% comeback from a 12-month low price of $0.3. It was seen 14.71% higher, changing the price to $0.39, when the closing bell rang on 9/13/2017. At recent session, the prices were hovering between $0.32 and $0.39. This company shares are 669.23% off its target price of $3 and the current market capitalization stands at $2.96M. The recent change has given its price a -7.31% deficit over SMA 50 and -91.12% deficit over its 52-week high. The stock witnessed -2.5% declines, -29.09% declines and -58.51% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found NSPR’s volatility during a week at 9.83% and during a month it has been found around 11.3%.InspireMD, Inc. (NSPR) Top Holders
Institutional investors currently hold around $1 million or 48.1% in NSPR stock. Look at its top three institutional owners. Sabby Management, Llc owns $1.1 million in InspireMD, Inc., which represents roughly 37.16% of the company’s market cap and approximately 110% of the institutional ownership. Similar statistics are true for the second largest owner, Virtu Kcg Holdings Llc, which owns 260,387 shares of the stock are valued at $89 thousand. The third largest holder is Anson Funds Management Lp, which currently holds $21 thousand worth of this stock and that ownership represents nearly 0.71% of its market capitalization.InspireMD, Inc. 13F Filings
At the end of 6/30/2017 reporting period, 2 institutional holders increased their position in InspireMD, Inc. (NYSE:NSPR) by some 3,199,894 shares, 6 decreased positions by 38,259 and 4 held positions by 346,106. That puts total institutional holdings at 3,584,259 shares, according to SEC filings. The stock grabbed new institutional investments totaling shares while 4 institutional investors sold out their entire positions totaling 23,673 shares.
Multiple company employees have indulged in significant insider trading. InspireMD, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director Barer Sol J has acquired 33,898 shares of InspireMD, Inc. (NSPR) in trading session dated Mar. 21, 2016. These shares are worth $499,996 and were traded at $14.75 each. The SEC filing shows that Loughlin James J performed a purchase of 2,000 shares. The Director added these shares by way of transaction on Mar. 21, 2016. The company’s shares were assimilated at $14.75 per share worth to an investment of some $29,500 on account of Loughlin James J.
Director, Rogers Campbell, purchased 339 common shares of InspireMD, Inc. (NSPR) in the open market. In a transaction dated Mar. 21, 2016, the shares were bought at an average price of $14.75, giving away a sum of $5,000. After this purchase, 339 common shares of NSPR are directly owned by the insider, with total stake valued at $132.
In the transaction dated Mar. 21, 2016, the great number of shares acquired came courtesy the Director; Stuka Paul added a total of 5,085 shares at an average price of $14.75, amounting to approximately $75,004. The insider now directly owns 10,682 shares worth $4,166.